INES PULIDO ENDRINO-rekin lankidetzan egindako argitalpenak (5)

2024

  1. Deciphering fibroblast-induced drug resistance in non-small cell lung carcinoma through patient-derived organoids in agarose microwells

    Lab on a Chip

2022

  1. A Very Rare Variant in SREBF2, a Possible Cause of Hypercholesterolemia and Increased Glycemic Levels

    Biomedicines, Vol. 10, Núm. 5

2020

  1. Endothelin-1-mediated drug resistance in EGFR-mutant non-small cell lung carcinoma

    Cancer Research, Vol. 80, Núm. 19, pp. 4224-4232

2019

  1. CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC

    Cancer Research, Vol. 79, Núm. 17, pp. 4439-4452

2015

  1. Intratumoral heterogeneity in EGFR-mutant NSCLC results in divergent resistance mechanisms in response to EGFR tyrosine kinase inhibition

    Cancer Research, Vol. 75, Núm. 20, pp. 4372-4383